References
- Li C, Siragy HM. Autophagy upregulates (Pro)renin receptor expression via reduction of P62/SQSTM1 and activation of ERK1/2 signaling pathway in podocytes. Am J Physiol Regul Integr Comp Physiol. 2017;313(1): R58–R64.
- Yi M, Zhang L, Liu Y, et al. Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy. Am J Physiol Renal Physiol. 2017;313(1): F74–F84.
- Huang SS, Ding DF, Chen S, et al. Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy. Sci Rep. 2017;7(1):45692.
- Sun L, Chen Z, Liu X, et al. Curcumin ameliorates epithelial-to-mesenchymal transition of podocytes in vivo and in vitro via regulating caveolin-1. Biomed Pharmacother. 2014;68(8):1079–1088.
- Hurcombe JA, Hartley P, Lay AC, et al. Podocyte GSK3 is an evolutionarily conserved critical regulator of kidney function. Nat Commun. 2019;10(1):403–403.
- Ollero M, Sahali D. Inhibition of the VEGF signalling pathway and glomerular disorder. Nephrol Dial Transplant. 2015;30(9):1449–1455.
- Fang L, Li X, Luo Y, et al. Autophagy inhibition induces podocyte apoptosis by activating the pro-apoptotic pathway of endoplasmic reticulum stress. Exp Cell Res. 2014;322(2):290–301.
- Liebau MC, Braun F, Höpker K, et al. Dysregulated autophagy contributes to podocyte damage in Fabry’s disease. PLoS One. 2013;8(5):e63506.
- Wei Q, Dong Z. HDAC4 blocks autophagy to trigger podocyte injury: non-epigenetic action in diabetic nephropathy. Kidney Int. 2014; 86(4):666–668.
- Xu D, Lao Y, Xu N, et al. Identification and characterization of anticancer compounds targeting apoptosis and autophagy from Chinese native garcinia species. Planta Med. 2015;81(1):79–89.
- Li X, Li H, Ye H, et al. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR. Am J Kidney Dis. 2009;54(1):51–58.
- Shengyou YY, Li H, Zhihong , et al. Influence of tacrolimus on podocyte injury inducted by angiotensin II. J Renin Angiotensin Aldosterone Syst. 2015;16(2):260–266.
- Miner JH. Glomerular filtration: the charge debate charges ahead. Kidney Int. 2008;74(3):259–261.
- Kume S, Yamahara K, Yasuda M, et al. Autophagy: emerging therapeutic target for diabetic nephropathy. Semin Nephrol. 2014; 34(1):9–16.
- Jiang X, Chen X, Wan J, et al. Autophagy protects against palmitic acid-induced apoptosis in podocytes in vitro. Sci Rep. 2017;7(1):42764.
- Gong J, Jin J, Zhao L, et al. Tripterygium glycoside protects against puromycin amino nucleoside-induced podocyte injury by upregulating autophagy. Int J Mol Med. 2018;42(1):115–122.
- Xu MY, Kim YS. Antitumor activity of glycyrol via induction of cell cycle arrest, apoptosis and defective autophagy. Food Chem Toxicol. 2014;74C:311–319.
- Qin Y, Zhou Z-W, Pan S-T, et al. Graphene quantum dots induce apoptosis, autophagy, and inflammatory response via p38 mitogen-activated protein kinase and nuclear factor-κB mediated signaling pathways in activated THP-1 macrophages . Toxicology. 2015;327:62–76.
- Chatterjee A, Chattopadhyay D, Chakrabarti G. MiR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis. Cell Signal. 2015;27(2):189–203.
- Zhang H, Tang J, Li C, et al. MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells. Cancer Lett. 2015;356(2):781–790.
- Ouyang L, Chen Y, Wang X-Y, et al. Polygonatum odoratum lectin induces apoptosis and autophagy via targeting EGFR-mediated Ras-Raf-MEK-ERK pathway in human MCF-7 breast cancer cells. Phytomedicine. 2014;21(12):1658–1665.
- Aramburu J, Heitman J, Crabtree GR. Calcineurin:a central controller of signalling in eukaryotes. EMBO Rep. 2004;5(4):343–348.
- Sigaroudi A, Jetter A, Mueller TF, et al. Severe reduction in tacrolimus concentrations with concomitant metamizole (dipyrone) therapy in transplant patients. Eur J Clin Pharmacol. 2019;75:869–872.
- Grunebaum E, Avitzur Y. Liver-associated immune abnormalities. Autoimmun Rev. 2019;18(1):15–20.
- Montano-Loza AJ, Hansen BE, Corpechot C, et al. Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on graft and patient survival. Gastroenterology. 2019;156(1):96–107.
- Shen X, Jiang H, Ying M, et al. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models. Sci Rep. 2016;6(1):32087.
- Supavekin S, Surapaitoolkorn W, Kurupong T, et al. Tacrolimus in steroid resistant and steroid dependent childhood nephrotic syndrome. J Med Assoc Thai. 2013;96(1):33–40.
- Wang W, Xia Y, Mao J, et al. Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome. Pediatr Nephrol. 2012;27(11):2073–2079.
- Shengyou Y, Li Y. Dexamethasone inhibits podocyte apoptosis by stabilizing the PI3K/Akt signal pathway. BioMed Res Int. 2013; 2013:1–9.
- Shengyou Y, Li Y. The effects of siRNA-silenced TRPC6 on podocyte autophagy and apoptosis induced by AngII. J Renin Angiotensin Aldosterone Syst. 2015;16(4):1266–1273.